BICO Group AB
STO:BICO
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Estee Lauder Companies Inc
NYSE:EL
|
Consumer products
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Church & Dwight Co Inc
NYSE:CHD
|
Consumer products
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
American Express Co
NYSE:AXP
|
Financial Services
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Target Corp
NYSE:TGT
|
Retail
|
|
US |
Walt Disney Co
NYSE:DIS
|
Media
|
|
US |
Mueller Industries Inc
NYSE:MLI
|
Machinery
|
|
US |
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
36.6
69.8
|
Price Target |
|
We'll email you a reminder when the closing price reaches SEK.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Estee Lauder Companies Inc
NYSE:EL
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Church & Dwight Co Inc
NYSE:CHD
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
American Express Co
NYSE:AXP
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Target Corp
NYSE:TGT
|
US | |
Walt Disney Co
NYSE:DIS
|
US | |
Mueller Industries Inc
NYSE:MLI
|
US | |
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one BICO stock under the Base Case scenario is 63.21 SEK. Compared to the current market price of 36.9 SEK, BICO Group AB is Undervalued by 42%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
BICO Group AB
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for BICO cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
BICO Group AB
Balance Sheet Decomposition
BICO Group AB
Current Assets | 1.7B |
Cash & Short-Term Investments | 687.6m |
Receivables | 557m |
Other Current Assets | 476.6m |
Non-Current Assets | 4B |
Long-Term Investments | 49.1m |
PP&E | 681.9m |
Intangibles | 3.2B |
Other Non-Current Assets | 77.9m |
Current Liabilities | 602.4m |
Accounts Payable | 83.9m |
Accrued Liabilities | 161.3m |
Other Current Liabilities | 357.2m |
Non-Current Liabilities | 2.1B |
Long-Term Debt | 1.8B |
Other Non-Current Liabilities | 298.9m |
Earnings Waterfall
BICO Group AB
Revenue
|
2.3B
SEK
|
Cost of Revenue
|
-997.9m
SEK
|
Gross Profit
|
1.3B
SEK
|
Operating Expenses
|
-1.3B
SEK
|
Operating Income
|
-47.4m
SEK
|
Other Expenses
|
-1B
SEK
|
Net Income
|
-1.1B
SEK
|
Free Cash Flow Analysis
BICO Group AB
SEK | |
Free Cash Flow | SEK |
In Q2 2024, BICO reported sales of SEK 534 million, a slight decline in organic growth by 2% due to weak performance in Academia and Diagnostics segments. Adjusted EBITDA stood at SEK 46 million with a 9% margin. The net loss reached SEK 79 million. Notably, North American biosciences drove growth while Asia, especially China, saw a significant drop in sales. All business areas were profitable, with Bioprinting and Bioautomation showing mixed results. Strategic hires and cost control were emphasized, and updates on strategic priorities will be presented at the upcoming Capital Markets Day.
What is Earnings Call?
BICO Profitability Score
Profitability Due Diligence
BICO Group AB's profitability score is 33/100. The higher the profitability score, the more profitable the company is.
Score
BICO Group AB's profitability score is 33/100. The higher the profitability score, the more profitable the company is.
BICO Solvency Score
Solvency Due Diligence
BICO Group AB's solvency score is 48/100. The higher the solvency score, the more solvent the company is.
Score
BICO Group AB's solvency score is 48/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
BICO Price Targets Summary
BICO Group AB
According to Wall Street analysts, the average 1-year price target for BICO is 112.2 SEK with a low forecast of 90.9 SEK and a high forecast of 141.75 SEK.
Dividends
Current shareholder yield for BICO is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Profile
Country
Industry
Market Cap
Dividend Yield
Description
BICO Group AB is a bioconvergence company, which engages in the provision of technologies, products, and services to create, understand and master biology. The company is headquartered in Goeteborg, Vastra Gotalands and currently employs 890 full-time employees. The company went IPO on 2016-11-03. The firm focuses on the application areas of bioprinting, multiomics, cell line development, and diagnostics. The firm develops and markets technologies that enable researchers in the life sciences to culture cells in 3D, perform high-throughput drug screening and print human tissues and organs for the medical, pharmaceutical, and cosmetic industries. The Company’s operations divided in two segments: The Industrial Solutions segment that offers products within precision dispensing and biosensor technology for industrial customers, which make a high-capacity contribution to customers production; and The Laboratory Solutions segment that offers 3Dprinters, single- cell and liquid- dispensing instruments as well as services and consumables related to these products.
Contact
IPO
Employees
Officers
The intrinsic value of one BICO stock under the Base Case scenario is 63.21 SEK.
Compared to the current market price of 36.9 SEK, BICO Group AB is Undervalued by 42%.